Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,9299,half-life,In all cases the elimination of heptabarbital could be described by a single first-order process with an average half-life of 7.6 h (range 6.1 - 11.2 h).,Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9299/),h,7.6,12378,DB01354,Heptabarbital
,9299,bioavailability,The sodium salt had an average bioavailability of 83% relative to the free acid.,Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9299/),%,83,12379,DB01354,Heptabarbital
,9299,cumulative excretion,In some volunteers urinary excretion of unchanged heptabarbital was measured; cumulative excretion amounted to 0.16 - 0.30% of the administered dose.,Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. ,fe-Q44,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9299/),%,0.16 - 0.30,12380,DB01354,Heptabarbital
,9299,half-life,"In three volunteers the half-life of the drug prior to and after these experiments did not change, whereas in the other volunteer the half-life decreased from 7.1 to 4.6 h.",Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9299/),h,7.1,12381,DB01354,Heptabarbital
,9299,half-life,"In three volunteers the half-life of the drug prior to and after these experiments did not change, whereas in the other volunteer the half-life decreased from 7.1 to 4.6 h.",Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/9299/),h,4.6,12382,DB01354,Heptabarbital
,6134816,elimination half-lives,"In control rats (n = 8) elimination half-lives and intrinsic clearance values ranged between 13 to 28 min and 96 to 435 ml/min X kg for hexobarbital and between 8 to 21 min and 84 to 371 ml/min X kg for heptabarbital, respectively.",Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/6134816/),min,13 to 28,82642,DB01354,Heptabarbital
,6134816,intrinsic clearance,"In control rats (n = 8) elimination half-lives and intrinsic clearance values ranged between 13 to 28 min and 96 to 435 ml/min X kg for hexobarbital and between 8 to 21 min and 84 to 371 ml/min X kg for heptabarbital, respectively.",Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies. ,CLint -Q3,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6134816/),[ml] / [kg·min],96 to 435,82643,DB01354,Heptabarbital
,2907009,sleeping-times,The possible contribution of (inter)active metabolites to the pharmacological response of heptabarbital was determined by administration of different i.v. bolus doses (14.1-22.5 mg) resulting in widely differing sleeping-times (7 +/- 3 to 119 +/- 20 min).,Strategy to assess the role of (inter)active metabolites in pharmacodynamic studies in-vivo: a model study with heptabarbital. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2907009/),min,7,247739,DB01354,Heptabarbital
,2907009,sleeping-times,The possible contribution of (inter)active metabolites to the pharmacological response of heptabarbital was determined by administration of different i.v. bolus doses (14.1-22.5 mg) resulting in widely differing sleeping-times (7 +/- 3 to 119 +/- 20 min).,Strategy to assess the role of (inter)active metabolites in pharmacodynamic studies in-vivo: a model study with heptabarbital. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2907009/),min,119,247740,DB01354,Heptabarbital
